Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04579679
Title Open-Label Surufatinib in European Patients With NET
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hutchison Medipharma Limited
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | FRA | ESP | DEU

No variant requirements are available.